Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Prospective Case-Control Study of Cardiovascular Changes in Pregnancy Related Hypertensive Disorders

A legfontosabb adatok

Ki végzi
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Hol
Pittsburgh (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
12 fő vett részt
Kezdés
2021. júl. 1.
Befejezés
2024. jan. 17.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • ARTSENS Pen
A regiszteradat frissítve
2024. január 30.
Miért állt le
slow enrollment

Ki vehet részt

Életkor
18 év felett
Nem
Csak nők
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 17 feltétel megnézéseKevesebb

Egyéb feltételek

  • Case Inclusion Criteria:
  • Adult females age > 18 years
  • Must be able to read and understand English and consent for themselves
  • Must have a singleton pregnancy and a diagnosis of preeclampsia or gestational hypertension
  • Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks and then at 6-7 months; Case Exclusion Criteria:
  • Prior history of hypertension
  • Multiple pregnancies
  • Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease
  • Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures; Control Inclusion Criteria:
  • Adult females age > 18 years
  • Must be able to read and understand English and consent for themselves
  • Must have a singleton pregnancy and not have a prior or current diagnosis of hypertension
  • Must be willing and able to come to West Penn Hospital for post-partum visits at 6-8 weeks; Control Exclusion Criteria:
  • Prior history and/or current diagnosis of hypertension
  • Multiple pregnancies
  • Other comorbidities such as congenital heart disease, dialysis dependent renal failure, heroin abuse, cocaine abuse, pulmonary hypertension, congestive heart failure, autoimmune conditions such as SLE or severe lung disease
  • Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

Helyszínek itt: Egyesült Államok

  • West Penn HospitalPittsburgh, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a research study to understand the changes in the heart and the cardiovascular system that may occur in women who develop high blood pressure during pregnancy.

A vizsgálat 3 csoportja

  • Pregnant with Pre-eclampsiaA vizsgált kezelés

    There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit will be 6-7 months post partum where there is a collection of a clinical questionnaire, demographics, vitals, chart review, echocardiogram and vascular compliance will be re-measured.

    Kezelés: ARTSENS Pen

  • Pregnant with gestational hypertensionA vizsgált kezelés

    There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit will be 6-7 months post partum where there is a collection of a clinical questionnaire, demographics, vitals, chart review, echocardiogram and vascular compliance will be re-measured.

    Kezelés: ARTSENS Pen

  • Pregnant without Hypertension - ControlMár használt kezelés, összehasonlításként

    There will be an initial 'Pregnancy' visit within 7-10 days of the screening visit, when the subject will undergo an echocardiogram, have the vascular compliance measurements and will have blood drawn for measurement of serum biomarkers. The second study visit will be the '6-8 weeks post-partum' visit when the echocardiogram and vascular compliance will be re-measured, along with assessment of vitals and medication history. The third study visit is not applicable to the control group.

    Kezelés: ARTSENS Pen

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2024. január 30.